Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).

Name: Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).
Start: 2023-09-22
End: 2025-08-27
Location: AOK Lower Saxony. The health insurance company.

AOK Lower Saxony. The health insurance company. Germany has Released a tender for Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07). in Pharmaceuticals. The tender was released on Sep 22, 2023.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).

Deadline - Aug 27, 2025

MT reference number - 72068694

Product classification - Immunosuppressive agents

Organization Details:

Address - Germany

Contact details - 565656565

Tender notice no. - 76454545

MT Ref Id - 72068694

Document Type - Tender Notices

Notice Details and Documents:

Description - Conclusion of a non-exclusive discount contract in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient tocilizumab (ATC code: L04AC07) within the period from November 1st, 2023 to October 31st, 2025 with the possibilit y of concluding the contract at any time during the term (“open- house model”).

Mt Ref Id - 72068694

Deadline - Aug 27, 2025

View more tenders for

Pharmaceuticals Tenders Immunosuppressive agents Tenders Germany Tenders

Similar Tenders :

Most Searched